Early and midterm outcome of Multilayer Flow Modulator stent for complex aortic aneurysm treatment in Germany

The use of the MFM for endovascular treatment of complex aortic aneurysm in urgent cases appears to be technically feasible in terms of mortality and morbidity, with moderate 30-day and acceptable midterm outcomes. Reinterventions may be needed to expand the utility of outcomes.